1. Home
  2. NLSP vs AIHS Comparison

NLSP vs AIHS Comparison

Compare NLSP & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AIHS
  • Stock Information
  • Founded
  • NLSP 2015
  • AIHS N/A
  • Country
  • NLSP Switzerland
  • AIHS China
  • Employees
  • NLSP N/A
  • AIHS N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • NLSP Health Care
  • AIHS Finance
  • Exchange
  • NLSP Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • NLSP 8.2M
  • AIHS 10.1M
  • IPO Year
  • NLSP 2021
  • AIHS 2018
  • Fundamental
  • Price
  • NLSP $0.19
  • AIHS $0.92
  • Analyst Decision
  • NLSP Hold
  • AIHS
  • Analyst Count
  • NLSP 1
  • AIHS 0
  • Target Price
  • NLSP N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • AIHS 34.4K
  • Earning Date
  • NLSP 07-30-2024
  • AIHS 08-12-2024
  • Dividend Yield
  • NLSP N/A
  • AIHS N/A
  • EPS Growth
  • NLSP N/A
  • AIHS N/A
  • EPS
  • NLSP N/A
  • AIHS N/A
  • Revenue
  • NLSP N/A
  • AIHS $6,814,428.00
  • Revenue This Year
  • NLSP N/A
  • AIHS N/A
  • Revenue Next Year
  • NLSP N/A
  • AIHS N/A
  • P/E Ratio
  • NLSP N/A
  • AIHS N/A
  • Revenue Growth
  • NLSP N/A
  • AIHS N/A
  • 52 Week Low
  • NLSP $0.11
  • AIHS $0.20
  • 52 Week High
  • NLSP $1.21
  • AIHS $1.23
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • AIHS 45.57
  • Support Level
  • NLSP $0.19
  • AIHS $0.90
  • Resistance Level
  • NLSP $0.24
  • AIHS $1.00
  • Average True Range (ATR)
  • NLSP 0.03
  • AIHS 0.05
  • MACD
  • NLSP -0.00
  • AIHS -0.01
  • Stochastic Oscillator
  • NLSP 15.85
  • AIHS 10.53

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: